Pharmaceutical investment enterprise brand terminal how to price

In order to support the work of maintaining prices, it is necessary to achieve a high degree of unanimity among the pharmaceutical investment enterprise, especially the middle and senior managers of the company and the persons in charge of the regional markets. The recognition must be highly unified. Third, we must earnestly do a good job of ideological education for grass-roots employees in the regional market to ensure that the price-enhancing work can be enforced in all aspects without compromise. Pharmaceutical investment promotion companies must be highly ideologically recognized and support price-fixing work, have the determination and confidence to thoroughly rectify the current market conditions, and be able to accurately grasp the balance between current sales volume and future development, at the expense of current temporary sales. In exchange for a determination of market price stability.

The price promotion of pharmaceutical investment brand product channels must be conducted step-by-step, planned, and carried out step by step, and the key points of each measure must be designed, and the links between the various stages should be well-ordered. This is also a decision-maker should consider in advance. problem.

First, the pharmaceutical investment to choose a good agreement commercial company: to determine the regional market in the first-tier merchants and their corresponding secondary distributors as an agreement sales unit, so that they enjoy the agreement sales price and services. The primary criteria for screening primary quotients are: Regional mainstream pharmaceutical logistics distribution companies, their distribution can effectively solve the regional market product coverage requirements, but also must have better financial strength and warehousing capabilities.

The business philosophy of the first-tier merchants, especially the management and control ideas for the prices of pharmaceutical investment enterprises, must be able to maintain a high degree of consistency with the upstream industries, and have strong cooperation intentions and provide relevant resources and management capabilities, such as monitoring the storage of special varieties of libraries and Delivery, warehouse shipment flow tracking records, etc. The number of tier 1 or tier 2 merchants should be determined based on the market coverage of the pharmaceutical investment promotion brand in the target area, and the overlapping coverage rate of different commercial channels in the same region should not exceed 40% to avoid disruption due to price competition in the secret market between commercial channels. Market price stability.

Second, the pharmacy can be used as a regional second-tier commerce provider: The focus of the commerce and investment market personnel's commerce work is the management of the second-tier quotient, and the second-level commerce must be ordered and merged with the designated tier-1 commercial channel to facilitate the directional channel flow chain. Management. The secondary tier is mainly responsible for the terminal distribution of the products. The core of management lies in the orderly planning of the terminal coverage area and encourages distributors to orderly cover the market terminals.

The mainstream chain pharmacies in the regional pharmaceutical investment promotion brand market can be positioned as secondary distributors in the region, and carry out sifting management and designate the first-level merchants for their purchase to facilitate the smooth development of related work. It is not advisable to classify mainstream pharmacies in the pharmaceutical investment region as first- and third-tier merchants. It is suggested that the establishment of the three-tier commercial channels be avoided as much as possible, and channel links should be simplified as much as possible to lay the foundation for the implementation of the directional channel flow chain management.